Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 5, 2010, Pages 635-640

  Roh, Mi In ^a   Lim, Su Jin ^b   Ahn, Ji Min ^c   Lim, Jong Baek ^a   Kwon, Oh Woong ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b NUNE Eye Hospital   (South Korea)

^c Siloan Eye Hospital   (South Korea)

Author keywords

Age related macular degeneration; Aqueous humor; Bevacizumab; Interleukin 1; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; IMMUNOASSAY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT DURATION; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; AQUEOUS HUMOR; CHOROIDAL NEOVASCULARIZATION; CYTOKINES; FEMALE; HUMANS; IMMUNOASSAY; INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 77952094419     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1254-8     Document Type: Article

References (23)

1. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Genentech, Inc. Avastin (Bevacizumab). Draft labeling text. BL125085/145 Amendment. Revised February 2008:13. Available at: http://www.fda.gov/cder/foi/label/2008/125085s1451bl.pdf. Accessed July 7, 2008
2. A Kvanta PV Algvere L Berglin S Seregard 1996 Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor Invest Ophthalmol Vis Sci 37 1929 1934 1:STN:280: DyaK28zjsFWjsQ%3D%3D 8759365
3. RN Frank RH Amin D Eliott JE Puklin GW Abrams 1996 Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes Am J Ophthalmol 122 393 403 1:STN:280:DyaK28zoslWksA%3D%3D 8794712
4. RL Avery DJ Pieramici MD Rabena AA Castellarin MA Nasir MJ Giust 2006 Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 363 372 10.1016/j.ophtha.2005.11.019 16458968
5. ZF Bashshur A Bazarbachi A Schakal ZA Haddad CP El Haibi BN Noureddin 2006 Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration Am J Ophthalmol 142 1 9 10.1016/j.ajo.2006.02.037 1:CAS:528:DC%2BD28Xms1GktLg%3D 16815245 (Pubitemid 43946791)
6. A Melamud S Stinnett S Fekrat 2008 Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections Am J Ophthalmol 146 91 95 10.1016/j.ajo.2008.03. 014 1:CAS:528:DC%2BD1cXnsFGjtbc%3D 18455144
7. Q Zhu F Ziemssen S Henke-Fahle O Tatar P Szurman S Aisenbrey N Schneiderhan-Marra X Xu Tübingen Bevacizumab Study Group, Grisanti S 2008 Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization Ophthalmology 115 1750 1755 10.1016/j.ophtha.2008.04.023 18708261
8. JP Tong WM Chan DT Liu TY Lai KW Choy CP Pang DS Lam 2006 Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization Am J Ophthalmol 141 456 462 10.1016/j.ajo.2005.10.012 1:CAS:528: DC%2BD28XhsFGgtr0%3D 16490490 (Pubitemid 43265948)
9. JB Jonas M Neumaier 2007 Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema Ophthalmic Res 39 139 142 10.1159/000102935 1:CAS:528:DC%2BD2sXmvFSmsLk%3D 17505145 (Pubitemid 46975978)
10. Early Treatment Diabetic Retinopathy Study Group 1991 Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7 Ophthalmology 98 741 756
11. RM Molloy RI Mc Connell JV Lamont SP FitzGerald 2005 Automation of biochip array technology for quality results Clin Chem Lab Med 43 1303 1313 10.1515/CCLM.2005.224 1:CAS:528:DC%2BD28XitlOiug%3D%3D 16309365
12. MI Roh HS Kim JH Song JB Lim HJ Koh OW Kwon 2009 Concentration of cytokines in the aqueous humor of patients with naïve, recurrent, and regressed CNV associated with AMD after Bevacizumab treatment Retina 29 523 529 10.1097/IAE.0b013e318195cb15 19262441
13. LP Aiello RL Avery PG Arrigg BA Keyt HD Jampel ST Shah LR Pasquale H Thieme MA Iwamoto JE Park HV Nguyen LM Aiello N Ferrara GL King 1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1480 1487 10.1056/ NEJM199412013312203 1:STN:280:DyaK2M%2FlvFamsA%3D%3D 7526212 (Pubitemid 24356306)
14. H Funatsu H Yamashita H Noma T Mimura S Nakamura K Sakata S Hori 2005 Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients Graefes Arch Clin Exp Ophthalmol 243 3 817 10.1007/s00417-004-0950-7 1:CAS:528:DC%2BD2MXltVWmsA%3D%3D 15258777
15. SJ Bakri MR Snyder JM Reid JS Pulido RJ Singh 2007 Pharmacokinetics of intravitreal bevacizumab (Avastin) Ophthalmology 114 855 859 10.1016/j.ophtha.2007.01.017 17467524 (Pubitemid 46635858)
16. E Voronov DS Shouval Y Krelin E Cagnano D Benharroch Y Iwakura CA Dinarello RN Apte 2003 IL-1 is required for tumor invasiveness and angiogenesis Proc Natl Acad Sci USA 100 2645 2650 10.1073/pnas.0437939100 1:CAS:528:DC%2BD3sXitVaisbk%3D 12598651 (Pubitemid 36297552)
17. X Song E Voronov T Dvorkin E Fima E Cagnano D Benharroch Y Shendler O Bjorkdahl S Segal CA Dinarello RN Apte 2003 Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness J Immunol 171 6448 6456 1:CAS:528:DC%2BD3sXpsV2rsb8%3D 14662844
18. RA Kowluru S Odenbach 2004 Role of interleukin-1beta in the pathogenesis of diabetic retinopathy Br J Ophthalmol 88 1343 1347 10.1136/bjo.2003.038133 1:STN:280:DC%2BD2cvpvFyqsw%3D%3D 15377563 (Pubitemid 39312984)
19. H Oh H Takagi C Takagi K Suzuma A Otani K Ishida M Matsumura Y Ogura Y Honda 1999 The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes Invest Ophthalmol Vis Sci 40 1891 1898 1:STN:280:DyaK1Mzms1ymsA%3D%3D 10440240
20. Y Zou X Xu GC Chiou 2006 Effect of interleukin-1 blockers, CK112, and CK116 on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro J Ocul Pharmacol Ther 22 19 25 10.1089/jop.2006.22.19 1:CAS:528:DC%2BD28Xhsl2gsrw%3D 16503771 (Pubitemid 43364076)
21. M Ryuto M Ono H Izumi H Yoshida HA Weich K Kohno M Kuwano 1996 Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells: possible roles of Sp-1 J Biol Chem 271 28220 28228 10.1074/jbc.271.45.28220 1:CAS:528:DyaK28XmvVWksbc%3D 8910439 (Pubitemid 26374633)
22. S Yoshida M Ono T Shono H Izumi T Ishibashi H Suzuki M Kuwano 1997 Involvement of interleukin-8, vascular endothelial growth factor, and basic Fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis Mol Cell Biol 17 4015 4023 1:CAS:528:DyaK2sXktFOisrg%3D 9199336
23. H Torisu M Ono H Kiryu M Furue Y Ohmoto J Nakayama Y Nishioka S Sone M Kuwano 2000 Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNF alpha and IL-1 alpha Int J Cancer 85 182 188 1:CAS:528:DC%2BD3cXmsVCisg%3D%3D 10629075